Free tool
FAERS Monitor: Banzel
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 021911 or its brand name (Banzel, Rufinamide). Reports on generic versions are filed under their own applications.
Reports
2,630
Serious
1,882
72% of reports
Hospitalization
727
Death reported
154
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- seizure670
- drug ineffective408
- off label use256
- somnolence186
- diarrhoea120
- condition aggravated116
- fatigue111
- vomiting108
- drug interaction106
- multiple-drug resistance102
- generalised tonic-clonic seizure95
- decreased appetite91
- fall90
- hospitalisation88
- weight decreased87
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2007 | 2 |
| 2008 | 1 |
| 2009 | 38 |
| 2010 | 27 |
| 2011 | 23 |
| 2012 | 49 |
| 2013 | 63 |
| 2014 | 93 |
| 2015 | 113 |
| 2016 | 130 |
| 2017 | 97 |
| 2018 | 136 |
| 2019 | 284 |
| 2020 | 237 |
| 2021 | 288 |
| 2022 | 246 |
| 2023 | 161 |
| 2024 | 268 |
| 2025 | 229 |
| 2026 | 145 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,051,529 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| multiple-drug resistanceSignal | 102 | 272.0 | 224.1 | 26,375 |
| seizureSignal | 670 | 46.7 | 43.7 | 29,877 |
| generalised tonic-clonic seizureSignal | 95 | 46.2 | 37.9 | 4,133 |
| somnolenceSignal | 186 | 7.4 | 6.4 | 1,031 |
| drug interactionSignal | 106 | 5.3 | 4.4 | 373 |
| hospitalisationSignal | 88 | 4.6 | 3.7 | 245 |
| decreased appetiteSignal | 91 | 3.1 | 2.6 | 132 |
| condition aggravatedSignal | 116 | 3.1 | 2.6 | 160 |
| weight decreasedSignal | 87 | 2.5 | 2.0 | 77 |
| drug ineffectiveSignal | 408 | 2.5 | 2.3 | 381 |
| off label useSignal | 256 | 2.3 | 2.1 | 203 |
| fallSignal | 90 | 2.2 | 1.8 | 56 |
| vomiting | 108 | 1.8 | 1.5 | 41 |
| diarrhoea | 120 | 1.5 | 1.2 | 19 |
| fatigue | 111 | 1.1 | 1.0 | 2 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.